Research & Development
Policy & Regulation
Trends & Finance
FDA reissues EUA for Janssen COVID-19 vaccine, includes warning about risks of myocarditis, pericarditis
Specifically, the warning states that reports of adverse events after use of the vaccine under emergency use authorization (EUA) suggest increased risks of myocarditis and pericarditis, particularly from zero through seven days following vaccination.
March 14, 2023
Becton Dickinson HPV assay FDA approved with BD SurePath, Hologic ThinPrep Pap tests
The BD Onclarity HPV Assay individually tests for an extended set of HPV types, including HPV 31, which poses a higher risk for causing cervical precancer than HPV 18, Becton Dickinson said.
February 21, 2023
Qiagen obtains CE Mark for tuberculosis blood test
Qiagen’s Ipsogen JAK2 RGQ PCR kit and NeuMoDx systems and reagents have already received CE Marks under the new IVDR requirements; the firm has pledged to transition all of its products to meet the new EU IVDR regulations.
February 15, 2023
New York State Department of Health approves PreciseDx breast cancer LDT
With the approval, PreciseDx can begin testing patient samples using its PDxBr test in the state of New York through its CLIA-certified laboratory.
February 7, 2023
FoundationOne Liquid CDx receives FDA approval for use with Rozlytrek (entrectinib)
The CDx is indicated for use with patients who do not have a tissue sample available and may be appropriate for treatment with Rozlytrek (entrectinib), a targeted therapy developed by Genentech.
January 4, 2023
Virax Biolabs obtains CE Mark, introduces human papillomavirus test kit
The HPV test kit covers 18 genotypes of the human papillomavirus, including type 53, which is higher risk and becoming increasingly prevalent.
January 4, 2023
Genetic causes identified for three rare diseases
Researchers in study validate test to identify newborns with homocystinuria, a rare inherited disease
SARS-CoV-2 infection weakens immune-cell response to vaccination, study suggests
Duke University researchers discover biomarkers may identify early pancreatic cancer risk
Werfen completes $2B acquisition of Immucor, expands presence in specialized diagnostics
Chembio CEO urges stockholders to tender remaining shares as deadline is extended for acquisition
Foundation Medicine obtains FDA approval for NSCLC CDx
The blood-based test’s first group approval improves physicians’ ability to identify patients in this population for treatment with certain FDA-approved tyrosine kinase inhibitors, Foundation Medicine said.
December 21, 2022
Thermo Fisher Scientific updates Applied Biosystems genetic analyzers to comply with IVDR
IVDR-compliant versions of both analyzers and corresponding consumables are now available in the majority of EU territories.
November 28, 2022
PerkinElmer nabs first FDA authorization for assay to screen for spinal muscular atrophy in newborns
The assay may be used by certified laboratories for the simultaneous detection of spinal muscular atrophy and severe combined immunodeficiency in newborns.
November 14, 2022
AMP update: Roche obtains regulatory approvals for six assays on compact MDx system
The approvals are part of an overall plan to make the broad menu of tests already running on its high-throughput Cobas 6800/8800 MDx systems also available on the more compact Cobas 5800.
November 7, 2022
Roche to launch compact MDx instrument at AMP meeting, obtains FDA premarket approval for HIV assay
Both the assay and system will be available in U.S. markets in Q4. Roche will showcase both this week at the Association for Molecular Pathology (AMP) 2022 Annual Meeting.
November 1, 2022
SQI Diagnostics nabs Health Canada approval for IL-6 triage test to detect COVID severity
By testing for the presence of IL-6, the tool helps identify patients at greatest risk of a severe inflammatory response from a cytokine storm, which is associated with the worst patient outcomes.
October 17, 2022
Page 1 of 3